Please find attahed statement of deviation and variation in utilization of funds raised through prresential issue for the quarter ended March 31, 2026
TIRUMALCHM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Thirumalai Chemicals Limited has filed a statement confirming no deviation or variation in the utilization of Rs. 5613.99 Lakhs raised through a Preferential Issue on December 18, 2025. The funds have been deployed across three areas: Rs. 3584.62 Lakhs towards investment in TCL Global BV (for onward investment into TCL Specialties LLC in the USA to fund capital expenditure), Rs. 2013.57 Lakhs for General Corporate Purposes, and Rs. 15.80 Lakhs for Issue Expenses. A small balance of Rs. 0.98 Lakhs remains in the Share Application Account pending utilization for General Corporate Purposes. The Audit Committee reviewed and approved this utilization statement on May 29, 2026.
The confirmation of no fund deviation is a positive signal for shareholders, indicating the company is executing its stated capital deployment plans as approved. The investment into TCL Specialties LLC in the USA suggests the company is pursuing overseas expansion through this preferential issue.